

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | biotin metabolic process (GO:0006768) | 6.66557247 |
| 2 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.98635189 |
| 3 | response to pheromone (GO:0019236) | 4.93169401 |
| 4 | intestinal cholesterol absorption (GO:0030299) | 4.78363732 |
| 5 | regulation of sarcomere organization (GO:0060297) | 4.60759303 |
| 6 | regulation of mitochondrial fission (GO:0090140) | 4.59601056 |
| 7 | negative regulation of heart growth (GO:0061117) | 4.58856863 |
| 8 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 4.58856863 |
| 9 | COPII vesicle coating (GO:0048208) | 4.36407679 |
| 10 | positive regulation of mitochondrial fission (GO:0090141) | 4.28157522 |
| 11 | phenylpropanoid metabolic process (GO:0009698) | 4.28099313 |
| 12 | vitamin biosynthetic process (GO:0009110) | 4.26294217 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.21744443 |
| 14 | short-chain fatty acid metabolic process (GO:0046459) | 4.19612577 |
| 15 | locomotory exploration behavior (GO:0035641) | 4.19494605 |
| 16 | synaptic vesicle maturation (GO:0016188) | 4.18333568 |
| 17 | cellular glucuronidation (GO:0052695) | 4.11936086 |
| 18 | cellular potassium ion homeostasis (GO:0030007) | 4.10804056 |
| 19 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.05969479 |
| 20 | positive regulation of receptor biosynthetic process (GO:0010870) | 4.05843560 |
| 21 | ectodermal placode formation (GO:0060788) | 4.05769582 |
| 22 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.03990928 |
| 23 | intestinal absorption (GO:0050892) | 4.02061200 |
| 24 | glutamate secretion (GO:0014047) | 3.97162360 |
| 25 | regulation of cholesterol metabolic process (GO:0090181) | 3.93819838 |
| 26 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.91582247 |
| 27 | uronic acid metabolic process (GO:0006063) | 3.90310295 |
| 28 | glucuronate metabolic process (GO:0019585) | 3.90310295 |
| 29 | mRNA modification (GO:0016556) | 3.87096599 |
| 30 | synaptic vesicle exocytosis (GO:0016079) | 3.82193831 |
| 31 | doxorubicin metabolic process (GO:0044598) | 3.76415717 |
| 32 | daunorubicin metabolic process (GO:0044597) | 3.76415717 |
| 33 | polyketide metabolic process (GO:0030638) | 3.76415717 |
| 34 | vocalization behavior (GO:0071625) | 3.74836886 |
| 35 | auditory receptor cell differentiation (GO:0042491) | 3.74065898 |
| 36 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.71883466 |
| 37 | snRNA processing (GO:0016180) | 3.67065478 |
| 38 | negative regulation of fibrinolysis (GO:0051918) | 3.66892424 |
| 39 | regulation of fibrinolysis (GO:0051917) | 3.66421548 |
| 40 | sodium ion export (GO:0071436) | 3.61015956 |
| 41 | receptor recycling (GO:0001881) | 3.58555106 |
| 42 | mitochondrial fission (GO:0000266) | 3.54257521 |
| 43 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.53953245 |
| 44 | negative regulation of sterol transport (GO:0032372) | 3.52227273 |
| 45 | negative regulation of cholesterol transport (GO:0032375) | 3.52227273 |
| 46 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.51390544 |
| 47 | snRNA metabolic process (GO:0016073) | 3.50615481 |
| 48 | bile acid metabolic process (GO:0008206) | 3.50350104 |
| 49 | blood coagulation, intrinsic pathway (GO:0007597) | 3.47182498 |
| 50 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.46872161 |
| 51 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.46096987 |
| 52 | neuronal action potential propagation (GO:0019227) | 3.45602348 |
| 53 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.43211879 |
| 54 | histone H4 deacetylation (GO:0070933) | 3.39429948 |
| 55 | regulation of DNA methylation (GO:0044030) | 3.39223451 |
| 56 | regulation of synaptic vesicle transport (GO:1902803) | 3.39161335 |
| 57 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.39022594 |
| 58 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.36174879 |
| 59 | tRNA methylation (GO:0030488) | 3.34934954 |
| 60 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.32287023 |
| 61 | microtubule depolymerization (GO:0007019) | 3.27655898 |
| 62 | NADH metabolic process (GO:0006734) | 3.26069361 |
| 63 | exploration behavior (GO:0035640) | 3.24766216 |
| 64 | regulation of bile acid biosynthetic process (GO:0070857) | 3.23730451 |
| 65 | neurotransmitter secretion (GO:0007269) | 3.22414714 |
| 66 | activation of protein kinase A activity (GO:0034199) | 3.21628631 |
| 67 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.20792465 |
| 68 | COPI coating of Golgi vesicle (GO:0048205) | 3.18763734 |
| 69 | Golgi transport vesicle coating (GO:0048200) | 3.18763734 |
| 70 | regulation of plasminogen activation (GO:0010755) | 3.17806968 |
| 71 | epoxygenase P450 pathway (GO:0019373) | 3.14906184 |
| 72 | regulation of protein activation cascade (GO:2000257) | 3.11231188 |
| 73 | nitrogen cycle metabolic process (GO:0071941) | 3.11157181 |
| 74 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.08694051 |
| 75 | cellular response to prostaglandin stimulus (GO:0071379) | 3.08592899 |
| 76 | glutamate receptor signaling pathway (GO:0007215) | 3.07774062 |
| 77 | response to prostaglandin E (GO:0034695) | 3.06178621 |
| 78 | L-phenylalanine catabolic process (GO:0006559) | 3.04927382 |
| 79 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.04927382 |
| 80 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.04442749 |
| 81 | L-phenylalanine metabolic process (GO:0006558) | 3.04442749 |
| 82 | protein carboxylation (GO:0018214) | 2.99320101 |
| 83 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.99320101 |
| 84 | chemosensory behavior (GO:0007635) | 2.98619470 |
| 85 | establishment of melanosome localization (GO:0032401) | 2.98430766 |
| 86 | neurofilament cytoskeleton organization (GO:0060052) | 2.95258616 |
| 87 | protein localization to synapse (GO:0035418) | 2.94420311 |
| 88 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.94246993 |
| 89 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.94172439 |
| 90 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.92507640 |
| 91 | cellular sodium ion homeostasis (GO:0006883) | 2.92457795 |
| 92 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.91067099 |
| 93 | urea metabolic process (GO:0019627) | 2.90450591 |
| 94 | long term synaptic depression (GO:0060292) | 2.88737873 |
| 95 | regulation of synapse structural plasticity (GO:0051823) | 2.88434425 |
| 96 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.87147184 |
| 97 | synaptic transmission, glutamatergic (GO:0035249) | 2.86907959 |
| 98 | melanosome transport (GO:0032402) | 2.86868239 |
| 99 | layer formation in cerebral cortex (GO:0021819) | 2.86363513 |
| 100 | regulation of helicase activity (GO:0051095) | 2.85566698 |
| 101 | rRNA catabolic process (GO:0016075) | 2.84714110 |
| 102 | regulation of complement activation (GO:0030449) | 2.84467337 |
| 103 | response to prostaglandin (GO:0034694) | 2.84062194 |
| 104 | eyelid development in camera-type eye (GO:0061029) | 2.83145729 |
| 105 | positive regulation of membrane potential (GO:0045838) | 2.81886747 |
| 106 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.81858557 |
| 107 | histone H3 deacetylation (GO:0070932) | 2.81491667 |
| 108 | establishment of pigment granule localization (GO:0051905) | 2.81056626 |
| 109 | regulation of synaptic plasticity (GO:0048167) | 2.80839200 |
| 110 | urate metabolic process (GO:0046415) | 2.80073468 |
| 111 | long-term memory (GO:0007616) | 2.79698087 |
| 112 | potassium ion import (GO:0010107) | 2.79556765 |
| 113 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.78941350 |
| 114 | regulation of ARF protein signal transduction (GO:0032012) | 2.78694064 |
| 115 | phospholipid dephosphorylation (GO:0046839) | 2.78354440 |
| 116 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.77350488 |
| 117 | oxaloacetate metabolic process (GO:0006107) | 2.75748852 |
| 118 | proline transport (GO:0015824) | 2.75629073 |
| 119 | gamma-aminobutyric acid transport (GO:0015812) | 2.75460392 |
| 120 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.75412493 |
| 121 | regulation of actin nucleation (GO:0051125) | 2.74987915 |
| 122 | cell communication by electrical coupling (GO:0010644) | 2.74929187 |
| 123 | exogenous drug catabolic process (GO:0042738) | 2.74626132 |
| 124 | glyoxylate metabolic process (GO:0046487) | 2.74576245 |
| 125 | proline biosynthetic process (GO:0006561) | 2.74352145 |
| 126 | interkinetic nuclear migration (GO:0022027) | 2.72818717 |
| 127 | vesicle transport along microtubule (GO:0047496) | 2.70872965 |
| 128 | neuron-neuron synaptic transmission (GO:0007270) | 2.70588807 |
| 129 | histone deubiquitination (GO:0016578) | 2.69877755 |
| 130 | regulation of postsynaptic membrane potential (GO:0060078) | 2.69856923 |
| 131 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.69603345 |
| 132 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.69324296 |
| 133 | pigment granule transport (GO:0051904) | 2.69229935 |
| 134 | positive regulation of vesicle fusion (GO:0031340) | 2.69177003 |
| 135 | definitive hemopoiesis (GO:0060216) | 2.68858776 |
| 136 | glutamate metabolic process (GO:0006536) | 2.68702812 |
| 137 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.68174867 |
| 138 | ncRNA catabolic process (GO:0034661) | 2.67105408 |
| 139 | long-term synaptic potentiation (GO:0060291) | 2.67011092 |
| 140 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.66870165 |
| 141 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.66165077 |
| 142 | detection of calcium ion (GO:0005513) | 2.65875644 |
| 143 | dendritic spine morphogenesis (GO:0060997) | 2.64117911 |
| 144 | regulation of RIG-I signaling pathway (GO:0039535) | 2.63990159 |
| 145 | phosphate ion transmembrane transport (GO:0035435) | 2.63925270 |
| 146 | urea cycle (GO:0000050) | 2.62275788 |
| 147 | drug catabolic process (GO:0042737) | 2.61755916 |
| 148 | neurotransmitter transport (GO:0006836) | 2.60745217 |
| 149 | phosphate ion transport (GO:0006817) | 2.60497522 |
| 150 | sulfur amino acid catabolic process (GO:0000098) | 2.60347348 |
| 151 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.59491904 |
| 152 | regulation of cholesterol homeostasis (GO:2000188) | 2.58668804 |
| 153 | cobalamin metabolic process (GO:0009235) | 2.58384371 |
| 154 | regulation of keratinocyte differentiation (GO:0045616) | 2.57084845 |
| 155 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.56538406 |
| 156 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.56481767 |
| 157 | bile acid biosynthetic process (GO:0006699) | 2.54474907 |
| 158 | purine ribonucleotide transport (GO:0015868) | 2.54395799 |
| 159 | protein targeting to Golgi (GO:0000042) | 2.53768885 |
| 160 | dendritic spine organization (GO:0097061) | 2.51901734 |
| 161 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.51679976 |
| 162 | cell communication involved in cardiac conduction (GO:0086065) | 2.51191981 |
| 163 | potassium ion homeostasis (GO:0055075) | 2.50078399 |
| 164 | regulation of vesicle fusion (GO:0031338) | 2.49614709 |
| 165 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.49389943 |
| 166 | neuron cell-cell adhesion (GO:0007158) | 2.47019841 |
| 167 | regulation of neurotransmitter levels (GO:0001505) | 2.46695030 |
| 168 | innervation (GO:0060384) | 2.45037658 |
| 169 | suckling behavior (GO:0001967) | 2.41578829 |
| 170 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.40891601 |
| 171 | neuromuscular process controlling balance (GO:0050885) | 2.39671137 |
| 172 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.37267281 |
| 173 | regulation of dendritic spine development (GO:0060998) | 2.36445093 |
| 174 | membrane repolarization (GO:0086009) | 2.33740571 |
| 175 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.33466827 |
| 176 | establishment of protein localization to Golgi (GO:0072600) | 2.32971699 |
| 177 | regulation of female receptivity (GO:0045924) | 2.32583197 |
| 178 | nerve growth factor signaling pathway (GO:0038180) | 2.32343175 |
| 179 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.31922734 |
| 180 | membrane repolarization during action potential (GO:0086011) | 2.30503957 |
| 181 | neuron recognition (GO:0008038) | 2.27880355 |
| 182 | mating behavior (GO:0007617) | 2.27677616 |
| 183 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.27221996 |
| 184 | positive regulation of synapse maturation (GO:0090129) | 2.26203104 |
| 185 | membrane depolarization (GO:0051899) | 2.24623098 |
| 186 | positive regulation of neurotransmitter transport (GO:0051590) | 2.24611266 |
| 187 | regulation of neurotransmitter secretion (GO:0046928) | 2.23471555 |
| 188 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.22722074 |
| 189 | cochlea development (GO:0090102) | 2.22217063 |
| 190 | response to histamine (GO:0034776) | 2.21514559 |
| 191 | alanine transport (GO:0032328) | 2.21062544 |
| 192 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.20283745 |
| 193 | relaxation of cardiac muscle (GO:0055119) | 2.19479768 |
| 194 | positive regulation of synaptic transmission (GO:0050806) | 2.17706086 |
| 195 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.16236521 |
| 196 | regulation of synaptic transmission (GO:0050804) | 2.15819440 |
| 197 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.15437093 |
| 198 | calcium ion-dependent exocytosis (GO:0017156) | 2.15330285 |
| 199 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.15190480 |
| 200 | positive regulation of exocytosis (GO:0045921) | 2.14327408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 5.92433258 |
| 2 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 5.76326038 |
| 3 | IGF1R_20145208_ChIP-Seq_DFB_Human | 4.44612715 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.21433794 |
| 5 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 3.38583813 |
| 6 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.29254574 |
| 7 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.51780884 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.42566478 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.36856591 |
| 10 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.34549164 |
| 11 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.34228015 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.33460073 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.30406935 |
| 14 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.24215113 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.23193067 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.18573715 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.16896165 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.15047831 |
| 19 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.14302227 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.08630659 |
| 21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.07234789 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.07234789 |
| 23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.06510136 |
| 24 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 2.04780125 |
| 25 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 2.04062829 |
| 26 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 2.03500346 |
| 27 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.01763118 |
| 28 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 2.00527567 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.96458989 |
| 30 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.94100919 |
| 31 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.91155605 |
| 32 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.87769418 |
| 33 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.87754062 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.87335852 |
| 35 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.85973918 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.83464574 |
| 37 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.81926272 |
| 38 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.80479491 |
| 39 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.80042683 |
| 40 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.78357612 |
| 41 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.73591296 |
| 42 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.71657789 |
| 43 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.70733880 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.69381983 |
| 45 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.69047345 |
| 46 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.68792555 |
| 47 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.63670901 |
| 48 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.63147179 |
| 49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.61309281 |
| 50 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.57131972 |
| 51 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.56540060 |
| 52 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.54113241 |
| 53 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.52866557 |
| 54 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.51097850 |
| 55 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.49325638 |
| 56 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.49124022 |
| 57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.43847880 |
| 58 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.43408665 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.42915294 |
| 60 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.41905639 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39811719 |
| 62 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.39629749 |
| 63 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.39183131 |
| 64 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.39181814 |
| 65 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.39064552 |
| 66 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.36296351 |
| 67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34320901 |
| 68 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.33688042 |
| 69 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32691957 |
| 70 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.32195685 |
| 71 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.31231557 |
| 72 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.31123136 |
| 73 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.30181236 |
| 74 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29344213 |
| 75 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.28713193 |
| 76 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.27689504 |
| 77 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27293278 |
| 78 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26734208 |
| 79 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.26412730 |
| 80 | FUS_26573619_Chip-Seq_HEK293_Human | 1.25939613 |
| 81 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.24093666 |
| 82 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22805367 |
| 83 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.20944314 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20840427 |
| 85 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.20798432 |
| 86 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.19828006 |
| 87 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.19400886 |
| 88 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19345144 |
| 89 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.19332942 |
| 90 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19173485 |
| 91 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.17342237 |
| 92 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.17036383 |
| 93 | MYC_22102868_ChIP-Seq_BL_Human | 1.15337510 |
| 94 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.14826373 |
| 95 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.14733016 |
| 96 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.14444884 |
| 97 | AR_25329375_ChIP-Seq_VCAP_Human | 1.13922164 |
| 98 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13552877 |
| 99 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12106691 |
| 100 | RXR_22108803_ChIP-Seq_LS180_Human | 1.11911047 |
| 101 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.11214113 |
| 102 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.10933854 |
| 103 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.10897052 |
| 104 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.10845551 |
| 105 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.09616240 |
| 106 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08736505 |
| 107 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.08712254 |
| 108 | TP53_16413492_ChIP-PET_HCT116_Human | 1.07915794 |
| 109 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07831002 |
| 110 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06650698 |
| 111 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.04465332 |
| 112 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04302550 |
| 113 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03994371 |
| 114 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.03299318 |
| 115 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03003273 |
| 116 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02976484 |
| 117 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02252505 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01738172 |
| 119 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01434732 |
| 120 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.00909728 |
| 121 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.00676423 |
| 122 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.00223437 |
| 123 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.99957794 |
| 124 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99920939 |
| 125 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99330033 |
| 126 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.99290260 |
| 127 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.99224659 |
| 128 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99222751 |
| 129 | AR_19668381_ChIP-Seq_PC3_Human | 0.99201513 |
| 130 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98756556 |
| 131 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98353343 |
| 132 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97139087 |
| 133 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97083500 |
| 134 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96768179 |
| 135 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96219447 |
| 136 | P300_19829295_ChIP-Seq_ESCs_Human | 0.95747818 |
| 137 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95566759 |
| 138 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.94796388 |
| 139 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94476590 |
| 140 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94367551 |
| 141 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93305944 |
| 142 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93305944 |
| 143 | STAT3_23295773_ChIP-Seq_U87_Human | 0.93263688 |
| 144 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92893010 |
| 145 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92022464 |
| 146 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.91711269 |
| 147 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.91512602 |
| 148 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.91366584 |
| 149 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91352791 |
| 150 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90895622 |
| 151 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.90852699 |
| 152 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90123673 |
| 153 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89597298 |
| 154 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.89275825 |
| 155 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.88978302 |
| 156 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.88690042 |
| 157 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.86630761 |
| 158 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86434230 |
| 159 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.84854925 |
| 160 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84504497 |
| 161 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.83954435 |
| 162 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83699559 |
| 163 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.83689311 |
| 164 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83251039 |
| 165 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82941470 |
| 166 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.81883902 |
| 167 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.81671100 |
| 168 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81546159 |
| 169 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.80855498 |
| 170 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.80579059 |
| 171 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.80530355 |
| 172 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.80222409 |
| 173 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80036258 |
| 174 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.79539900 |
| 175 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.79438441 |
| 176 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.78604932 |
| 177 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.78515956 |
| 178 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.78329352 |
| 179 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.77195521 |
| 180 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.76888616 |
| 181 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.75582752 |
| 182 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.74961182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.61945705 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.45292720 |
| 3 | MP0003880_abnormal_central_pattern | 3.42264357 |
| 4 | MP0004270_analgesia | 3.04994098 |
| 5 | MP0003122_maternal_imprinting | 3.03296363 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 2.94807898 |
| 7 | MP0003567_abnormal_fetal_cardiomyocyte | 2.86613821 |
| 8 | MP0002063_abnormal_learning/memory/cond | 2.64527730 |
| 9 | MP0009745_abnormal_behavioral_response | 2.63011967 |
| 10 | MP0002822_catalepsy | 2.58802988 |
| 11 | MP0009780_abnormal_chondrocyte_physiolo | 2.51829389 |
| 12 | MP0002909_abnormal_adrenal_gland | 2.46883059 |
| 13 | MP0002064_seizures | 2.42185961 |
| 14 | MP0003787_abnormal_imprinting | 2.41567051 |
| 15 | MP0003123_paternal_imprinting | 2.40277930 |
| 16 | MP0003329_amyloid_beta_deposits | 2.39154261 |
| 17 | MP0001188_hyperpigmentation | 2.36549830 |
| 18 | MP0004742_abnormal_vestibular_system | 2.28270679 |
| 19 | MP0005360_urolithiasis | 2.13232500 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.10737947 |
| 21 | MP0002572_abnormal_emotion/affect_behav | 2.07311475 |
| 22 | MP0002139_abnormal_hepatobiliary_system | 2.06538818 |
| 23 | MP0001968_abnormal_touch/_nociception | 2.01717791 |
| 24 | MP0009046_muscle_twitch | 1.96060029 |
| 25 | MP0004043_abnormal_pH_regulation | 1.92752722 |
| 26 | MP0003806_abnormal_nucleotide_metabolis | 1.92612162 |
| 27 | MP0002272_abnormal_nervous_system | 1.89258396 |
| 28 | MP0003121_genomic_imprinting | 1.81728899 |
| 29 | MP0008877_abnormal_DNA_methylation | 1.78694535 |
| 30 | MP0009384_cardiac_valve_regurgitation | 1.77810704 |
| 31 | MP0000013_abnormal_adipose_tissue | 1.74160534 |
| 32 | MP0001764_abnormal_homeostasis | 1.70035702 |
| 33 | MP0008875_abnormal_xenobiotic_pharmacok | 1.68954866 |
| 34 | MP0003195_calcinosis | 1.67919504 |
| 35 | MP0001486_abnormal_startle_reflex | 1.67473079 |
| 36 | MP0000516_abnormal_urinary_system | 1.66682962 |
| 37 | MP0005367_renal/urinary_system_phenotyp | 1.66682962 |
| 38 | MP0008569_lethality_at_weaning | 1.66147949 |
| 39 | MP0003718_maternal_effect | 1.62923914 |
| 40 | MP0005085_abnormal_gallbladder_physiolo | 1.57237358 |
| 41 | MP0001765_abnormal_ion_homeostasis | 1.57072811 |
| 42 | MP0003890_abnormal_embryonic-extraembry | 1.56424470 |
| 43 | MP0002009_preneoplasia | 1.54475393 |
| 44 | MP0002734_abnormal_mechanical_nocicepti | 1.51795420 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 1.50692875 |
| 46 | MP0000604_amyloidosis | 1.50203925 |
| 47 | MP0004130_abnormal_muscle_cell | 1.49816952 |
| 48 | MP0005365_abnormal_bile_salt | 1.49079200 |
| 49 | MP0001440_abnormal_grooming_behavior | 1.48198495 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.46803579 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.46627481 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.45600869 |
| 53 | MP0003633_abnormal_nervous_system | 1.45365117 |
| 54 | MP0005535_abnormal_body_temperature | 1.44997525 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.44974471 |
| 56 | MP0003879_abnormal_hair_cell | 1.44958831 |
| 57 | MP0000490_abnormal_crypts_of | 1.42938865 |
| 58 | MP0010329_abnormal_lipoprotein_level | 1.42389946 |
| 59 | MP0002736_abnormal_nociception_after | 1.40519326 |
| 60 | MP0010386_abnormal_urinary_bladder | 1.40095523 |
| 61 | MP0005423_abnormal_somatic_nervous | 1.37421309 |
| 62 | MP0004233_abnormal_muscle_weight | 1.36525679 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.36051027 |
| 64 | MP0002796_impaired_skin_barrier | 1.29710737 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.28712638 |
| 66 | MP0002733_abnormal_thermal_nociception | 1.28448142 |
| 67 | MP0002067_abnormal_sensory_capabilities | 1.28195510 |
| 68 | MP0003693_abnormal_embryo_hatching | 1.26926422 |
| 69 | MP0000566_synostosis | 1.25605484 |
| 70 | MP0003075_altered_response_to | 1.24829708 |
| 71 | MP0005501_abnormal_skin_physiology | 1.24150509 |
| 72 | MP0005645_abnormal_hypothalamus_physiol | 1.20183976 |
| 73 | MP0003941_abnormal_skin_development | 1.19999372 |
| 74 | MP0003943_abnormal_hepatobiliary_system | 1.19719852 |
| 75 | MP0001970_abnormal_pain_threshold | 1.19705120 |
| 76 | MP0001666_abnormal_nutrient_absorption | 1.18497278 |
| 77 | MP0004858_abnormal_nervous_system | 1.18264357 |
| 78 | MP0004811_abnormal_neuron_physiology | 1.16470874 |
| 79 | MP0003252_abnormal_bile_duct | 1.15316022 |
| 80 | MP0005386_behavior/neurological_phenoty | 1.15130219 |
| 81 | MP0004924_abnormal_behavior | 1.15130219 |
| 82 | MP0002877_abnormal_melanocyte_morpholog | 1.14783556 |
| 83 | MP0000609_abnormal_liver_physiology | 1.13890014 |
| 84 | MP0002557_abnormal_social/conspecific_i | 1.13800516 |
| 85 | MP0002735_abnormal_chemical_nociception | 1.13132569 |
| 86 | MP0001919_abnormal_reproductive_system | 1.12731486 |
| 87 | MP0004885_abnormal_endolymph | 1.11770666 |
| 88 | MP0001984_abnormal_olfaction | 1.09830613 |
| 89 | MP0006292_abnormal_olfactory_placode | 1.09825141 |
| 90 | MP0008872_abnormal_physiological_respon | 1.09409693 |
| 91 | MP0003763_abnormal_thymus_physiology | 1.08321517 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 1.07914063 |
| 93 | MP0002138_abnormal_hepatobiliary_system | 1.07624147 |
| 94 | MP0005332_abnormal_amino_acid | 1.07384659 |
| 95 | MP0001873_stomach_inflammation | 1.07198806 |
| 96 | MP0005248_abnormal_Harderian_gland | 1.06333306 |
| 97 | MP0003191_abnormal_cellular_cholesterol | 1.06326807 |
| 98 | MP0002118_abnormal_lipid_homeostasis | 1.06092173 |
| 99 | MP0003690_abnormal_glial_cell | 1.00715713 |
| 100 | MP0004484_altered_response_of | 0.98167937 |
| 101 | MP0000003_abnormal_adipose_tissue | 0.97427671 |
| 102 | MP0003631_nervous_system_phenotype | 0.96880340 |
| 103 | MP0002078_abnormal_glucose_homeostasis | 0.96162118 |
| 104 | MP0002184_abnormal_innervation | 0.95513127 |
| 105 | MP0004185_abnormal_adipocyte_glucose | 0.95001731 |
| 106 | MP0002066_abnormal_motor_capabilities/c | 0.94323758 |
| 107 | MP0008874_decreased_physiological_sensi | 0.94314348 |
| 108 | MP0002876_abnormal_thyroid_physiology | 0.94102573 |
| 109 | MP0001502_abnormal_circadian_rhythm | 0.92663113 |
| 110 | MP0009672_abnormal_birth_weight | 0.90265935 |
| 111 | MP0001944_abnormal_pancreas_morphology | 0.89033945 |
| 112 | MP0005646_abnormal_pituitary_gland | 0.86461764 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84967204 |
| 114 | MP0004215_abnormal_myocardial_fiber | 0.84522126 |
| 115 | MP0005375_adipose_tissue_phenotype | 0.84320360 |
| 116 | MP0001664_abnormal_digestion | 0.83635696 |
| 117 | MP0005666_abnormal_adipose_tissue | 0.83626813 |
| 118 | MP0003868_abnormal_feces_composition | 0.83420503 |
| 119 | MP0002069_abnormal_eating/drinking_beha | 0.83377938 |
| 120 | MP0005409_darkened_coat_color | 0.82502327 |
| 121 | MP0002693_abnormal_pancreas_physiology | 0.80900537 |
| 122 | MP0005084_abnormal_gallbladder_morpholo | 0.80728896 |
| 123 | MP0003183_abnormal_peptide_metabolism | 0.79674153 |
| 124 | MP0002971_abnormal_brown_adipose | 0.79581392 |
| 125 | MP0000462_abnormal_digestive_system | 0.79523208 |
| 126 | MP0000955_abnormal_spinal_cord | 0.77735159 |
| 127 | MP0004510_myositis | 0.76276628 |
| 128 | MP0002882_abnormal_neuron_morphology | 0.76143957 |
| 129 | MP0001915_intracranial_hemorrhage | 0.75812759 |
| 130 | MP0009643_abnormal_urine_homeostasis | 0.74787264 |
| 131 | MP0000598_abnormal_liver_morphology | 0.74233819 |
| 132 | MP0005408_hypopigmentation | 0.74168483 |
| 133 | MP0002234_abnormal_pharynx_morphology | 0.74127761 |
| 134 | MP0003315_abnormal_perineum_morphology | 0.73648199 |
| 135 | MP0004085_abnormal_heartbeat | 0.73016108 |
| 136 | MP0005636_abnormal_mineral_homeostasis | 0.72915041 |
| 137 | MP0001177_atelectasis | 0.71842540 |
| 138 | MP0004264_abnormal_extraembryonic_tissu | 0.70605742 |
| 139 | MP0005166_decreased_susceptibility_to | 0.70554601 |
| 140 | MP0002229_neurodegeneration | 0.70511951 |
| 141 | MP0004197_abnormal_fetal_growth/weight/ | 0.70499741 |
| 142 | MP0000778_abnormal_nervous_system | 0.68748582 |
| 143 | MP0003385_abnormal_body_wall | 0.68599775 |
| 144 | MP0002090_abnormal_vision | 0.68564859 |
| 145 | MP0002098_abnormal_vibrissa_morphology | 0.64513426 |
| 146 | MP0001727_abnormal_embryo_implantation | 0.64258108 |
| 147 | MP0003699_abnormal_female_reproductive | 0.63088775 |
| 148 | MP0005310_abnormal_salivary_gland | 0.62883710 |
| 149 | MP0001529_abnormal_vocalization | 0.62819814 |
| 150 | MP0005220_abnormal_exocrine_pancreas | 0.62526546 |
| 151 | MP0002697_abnormal_eye_size | 0.61375352 |
| 152 | MP0000477_abnormal_intestine_morphology | 0.61236507 |
| 153 | MP0009703_decreased_birth_body | 0.60624673 |
| 154 | MP0002928_abnormal_bile_duct | 0.58535721 |
| 155 | MP0005410_abnormal_fertilization | 0.56800496 |
| 156 | MP0002233_abnormal_nose_morphology | 0.55676311 |
| 157 | MP0000653_abnormal_sex_gland | 0.55162148 |
| 158 | MP0001485_abnormal_pinna_reflex | 0.53940945 |
| 159 | MP0004381_abnormal_hair_follicle | 0.53329559 |
| 160 | MP0000681_abnormal_thyroid_gland | 0.52549577 |
| 161 | MP0009642_abnormal_blood_homeostasis | 0.52063852 |
| 162 | MP0000538_abnormal_urinary_bladder | 0.51098642 |
| 163 | MP0005376_homeostasis/metabolism_phenot | 0.50551705 |
| 164 | MP0009250_abnormal_appendicular_skeleto | 0.48485832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinemia (HP:0002154) | 6.27450643 |
| 2 | Focal motor seizures (HP:0011153) | 5.98686795 |
| 3 | Conjugated hyperbilirubinemia (HP:0002908) | 5.02229013 |
| 4 | Myokymia (HP:0002411) | 4.65422296 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 4.56433748 |
| 6 | Visual hallucinations (HP:0002367) | 4.41075345 |
| 7 | Renal cortical cysts (HP:0000803) | 4.29309537 |
| 8 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.21901058 |
| 9 | Abnormality of glycine metabolism (HP:0010895) | 4.21901058 |
| 10 | Focal seizures (HP:0007359) | 4.16150999 |
| 11 | Limb hypertonia (HP:0002509) | 3.63622868 |
| 12 | Absence seizures (HP:0002121) | 3.59445835 |
| 13 | Methylmalonic acidemia (HP:0002912) | 3.54293895 |
| 14 | Epileptic encephalopathy (HP:0200134) | 3.43098686 |
| 15 | Abnormal foot bone ossification (HP:0010675) | 3.42716795 |
| 16 | Joint hemorrhage (HP:0005261) | 3.42108537 |
| 17 | Atonic seizures (HP:0010819) | 3.39100851 |
| 18 | Hyperammonemia (HP:0001987) | 3.32437513 |
| 19 | Osteomalacia (HP:0002749) | 3.30800804 |
| 20 | Hyperglycinuria (HP:0003108) | 3.22403429 |
| 21 | Nephrogenic diabetes insipidus (HP:0009806) | 3.21039860 |
| 22 | Action tremor (HP:0002345) | 3.18912775 |
| 23 | Papillary thyroid carcinoma (HP:0002895) | 3.17607403 |
| 24 | Dialeptic seizures (HP:0011146) | 3.14285473 |
| 25 | Cerebral inclusion bodies (HP:0100314) | 3.14069294 |
| 26 | Cheilitis (HP:0100825) | 3.11535931 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.10648293 |
| 28 | Generalized tonic-clonic seizures (HP:0002069) | 3.03241059 |
| 29 | Hypobetalipoproteinemia (HP:0003563) | 2.97565767 |
| 30 | Ketoacidosis (HP:0001993) | 2.94038239 |
| 31 | Hyperventilation (HP:0002883) | 2.90744104 |
| 32 | Neurofibrillary tangles (HP:0002185) | 2.89107390 |
| 33 | Papilledema (HP:0001085) | 2.85996954 |
| 34 | Fat malabsorption (HP:0002630) | 2.85846528 |
| 35 | Anxiety (HP:0000739) | 2.85019132 |
| 36 | Impaired social interactions (HP:0000735) | 2.84130209 |
| 37 | Abnormal social behavior (HP:0012433) | 2.84130209 |
| 38 | Supranuclear gaze palsy (HP:0000605) | 2.80917557 |
| 39 | Abnormality of vitamin metabolism (HP:0100508) | 2.78812736 |
| 40 | Intention tremor (HP:0002080) | 2.74916957 |
| 41 | Poor eye contact (HP:0000817) | 2.73696091 |
| 42 | Depression (HP:0000716) | 2.71599755 |
| 43 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.67741391 |
| 44 | Ventricular fibrillation (HP:0001663) | 2.64971615 |
| 45 | Progressive cerebellar ataxia (HP:0002073) | 2.64880100 |
| 46 | Dysmetria (HP:0001310) | 2.64638003 |
| 47 | Febrile seizures (HP:0002373) | 2.59907417 |
| 48 | Hyperphosphaturia (HP:0003109) | 2.59219427 |
| 49 | Hypoglycemic coma (HP:0001325) | 2.57557028 |
| 50 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.56676012 |
| 51 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.54433248 |
| 52 | Increased circulating renin level (HP:0000848) | 2.54289441 |
| 53 | Hemiplegia (HP:0002301) | 2.52790608 |
| 54 | Hypercholesterolemia (HP:0003124) | 2.52438981 |
| 55 | Tachypnea (HP:0002789) | 2.52425895 |
| 56 | Status epilepticus (HP:0002133) | 2.49270850 |
| 57 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.47782389 |
| 58 | Agitation (HP:0000713) | 2.46717403 |
| 59 | Abnormality of oral frenula (HP:0000190) | 2.46388713 |
| 60 | Methylmalonic aciduria (HP:0012120) | 2.45529812 |
| 61 | Scanning speech (HP:0002168) | 2.45210138 |
| 62 | Truncal ataxia (HP:0002078) | 2.45082105 |
| 63 | Gout (HP:0001997) | 2.41992964 |
| 64 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.41954751 |
| 65 | Postural instability (HP:0002172) | 2.40624345 |
| 66 | Dysdiadochokinesis (HP:0002075) | 2.40150530 |
| 67 | Ketosis (HP:0001946) | 2.37297118 |
| 68 | Metabolic acidosis (HP:0001942) | 2.36040416 |
| 69 | Abnormality of vitamin B metabolism (HP:0004340) | 2.33973422 |
| 70 | Abnormal eating behavior (HP:0100738) | 2.32799361 |
| 71 | Abnormal urine phosphate concentration (HP:0012599) | 2.31108916 |
| 72 | Hyperactive renin-angiotensin system (HP:0000841) | 2.29731987 |
| 73 | Impaired smooth pursuit (HP:0007772) | 2.26137281 |
| 74 | Steatorrhea (HP:0002570) | 2.25916427 |
| 75 | Clitoromegaly (HP:0000057) | 2.24772821 |
| 76 | Gaze-evoked nystagmus (HP:0000640) | 2.23424537 |
| 77 | Widely patent fontanelles and sutures (HP:0004492) | 2.22369072 |
| 78 | Menstrual irregularities (HP:0000858) | 2.21851412 |
| 79 | Hepatoblastoma (HP:0002884) | 2.21287951 |
| 80 | Global brain atrophy (HP:0002283) | 2.19719278 |
| 81 | Intrahepatic cholestasis (HP:0001406) | 2.17427975 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 2.15903537 |
| 83 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.15903537 |
| 84 | Dysmetric saccades (HP:0000641) | 2.15902614 |
| 85 | Progressive inability to walk (HP:0002505) | 2.14201071 |
| 86 | Proximal tubulopathy (HP:0000114) | 2.14098235 |
| 87 | Gait imbalance (HP:0002141) | 2.13236351 |
| 88 | Abnormality of binocular vision (HP:0011514) | 2.12879085 |
| 89 | Diplopia (HP:0000651) | 2.12879085 |
| 90 | Amblyopia (HP:0000646) | 2.11561210 |
| 91 | Congenital primary aphakia (HP:0007707) | 2.09576252 |
| 92 | Mutism (HP:0002300) | 2.09555461 |
| 93 | Germ cell neoplasia (HP:0100728) | 2.09535098 |
| 94 | Stereotypic behavior (HP:0000733) | 2.09288839 |
| 95 | Megalencephaly (HP:0001355) | 2.07873680 |
| 96 | Thickened nuchal skin fold (HP:0000474) | 2.07057747 |
| 97 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.06454077 |
| 98 | Hemiparesis (HP:0001269) | 2.06354463 |
| 99 | Epileptiform EEG discharges (HP:0011182) | 2.06273084 |
| 100 | Hip dysplasia (HP:0001385) | 2.06148703 |
| 101 | Decreased circulating renin level (HP:0003351) | 2.05375352 |
| 102 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.05215415 |
| 103 | Severe Myopia (HP:0011003) | 2.03677626 |
| 104 | Broad-based gait (HP:0002136) | 2.03447818 |
| 105 | Renal tubular dysfunction (HP:0000124) | 2.02512080 |
| 106 | Bundle branch block (HP:0011710) | 2.01598671 |
| 107 | Drooling (HP:0002307) | 2.00464436 |
| 108 | Excessive salivation (HP:0003781) | 2.00464436 |
| 109 | Ankle clonus (HP:0011448) | 2.00231409 |
| 110 | Syncope (HP:0001279) | 2.00120159 |
| 111 | Absent eyebrow (HP:0002223) | 1.99823937 |
| 112 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.97310574 |
| 113 | Thyroid carcinoma (HP:0002890) | 1.96666140 |
| 114 | Focal dystonia (HP:0004373) | 1.95378744 |
| 115 | Torticollis (HP:0000473) | 1.93063462 |
| 116 | Metabolic alkalosis (HP:0200114) | 1.92892688 |
| 117 | Abnormality of serum amino acid levels (HP:0003112) | 1.92654320 |
| 118 | Bradykinesia (HP:0002067) | 1.91781121 |
| 119 | Renal tubular acidosis (HP:0001947) | 1.91400120 |
| 120 | Pheochromocytoma (HP:0002666) | 1.90551192 |
| 121 | EEG with generalized epileptiform discharges (HP:0011198) | 1.88233525 |
| 122 | Abnormality of renin-angiotensin system (HP:0000847) | 1.87072762 |
| 123 | Rickets (HP:0002748) | 1.87071383 |
| 124 | Deep venous thrombosis (HP:0002625) | 1.86996566 |
| 125 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.86847411 |
| 126 | Neuronal loss in central nervous system (HP:0002529) | 1.85793672 |
| 127 | Abnormality of the Achilles tendon (HP:0005109) | 1.85732576 |
| 128 | Barrel-shaped chest (HP:0001552) | 1.84279505 |
| 129 | Gingival bleeding (HP:0000225) | 1.83053682 |
| 130 | Genital tract atresia (HP:0001827) | 1.82835890 |
| 131 | Hyperbilirubinemia (HP:0002904) | 1.82109524 |
| 132 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.81595841 |
| 133 | Lower limb asymmetry (HP:0100559) | 1.80817101 |
| 134 | Abnormal vertebral ossification (HP:0100569) | 1.80125189 |
| 135 | Hypoglycemic seizures (HP:0002173) | 1.80098731 |
| 136 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.80040031 |
| 137 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.79852079 |
| 138 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.79852079 |
| 139 | Medial flaring of the eyebrow (HP:0010747) | 1.79487038 |
| 140 | Urinary urgency (HP:0000012) | 1.79300048 |
| 141 | Abnormality of the alveolar ridges (HP:0006477) | 1.79182031 |
| 142 | Type II lissencephaly (HP:0007260) | 1.78905823 |
| 143 | Rapidly progressive (HP:0003678) | 1.78749950 |
| 144 | Hepatitis (HP:0012115) | 1.78712736 |
| 145 | Xanthomatosis (HP:0000991) | 1.78147006 |
| 146 | Female pseudohermaphroditism (HP:0010458) | 1.78060332 |
| 147 | Medulloblastoma (HP:0002885) | 1.76965498 |
| 148 | Acanthocytosis (HP:0001927) | 1.76825706 |
| 149 | Hyperparathyroidism (HP:0000843) | 1.76623899 |
| 150 | Achilles tendon contracture (HP:0001771) | 1.76165673 |
| 151 | Cerebral hemorrhage (HP:0001342) | 1.76082364 |
| 152 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.75971576 |
| 153 | Termporal pattern (HP:0011008) | 1.75026721 |
| 154 | Insidious onset (HP:0003587) | 1.75026721 |
| 155 | Epidermoid cyst (HP:0200040) | 1.74574358 |
| 156 | Hypsarrhythmia (HP:0002521) | 1.74422399 |
| 157 | Vaginal atresia (HP:0000148) | 1.74268689 |
| 158 | Psychosis (HP:0000709) | 1.74174334 |
| 159 | Impaired vibratory sensation (HP:0002495) | 1.74078823 |
| 160 | Hypokalemic alkalosis (HP:0001949) | 1.72628977 |
| 161 | Glycosuria (HP:0003076) | 1.72573275 |
| 162 | Abnormality of urine glucose concentration (HP:0011016) | 1.72573275 |
| 163 | Abnormality of the gastric mucosa (HP:0004295) | 1.72260603 |
| 164 | Absent eyelashes (HP:0000561) | 1.72081901 |
| 165 | Cystic hygroma (HP:0000476) | 1.71744802 |
| 166 | Generalized myoclonic seizures (HP:0002123) | 1.71694992 |
| 167 | Hypercortisolism (HP:0001578) | 1.71508195 |
| 168 | Sensorimotor neuropathy (HP:0007141) | 1.71479313 |
| 169 | Renal Fanconi syndrome (HP:0001994) | 1.69908245 |
| 170 | Gait ataxia (HP:0002066) | 1.69777423 |
| 171 | Abnormality of the common coagulation pathway (HP:0010990) | 1.69594929 |
| 172 | Dysostosis multiplex (HP:0000943) | 1.69419722 |
| 173 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.68932620 |
| 174 | Hyperlipoproteinemia (HP:0010980) | 1.68651752 |
| 175 | Right ventricular cardiomyopathy (HP:0011663) | 1.67675756 |
| 176 | Spastic gait (HP:0002064) | 1.67667224 |
| 177 | Hypoplastic ischia (HP:0003175) | 1.67240603 |
| 178 | Late onset (HP:0003584) | 1.66967085 |
| 179 | Polygenic inheritance (HP:0010982) | 1.66772601 |
| 180 | Abnormality of the corticospinal tract (HP:0002492) | 1.66740482 |
| 181 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.66602110 |
| 182 | Lissencephaly (HP:0001339) | 1.66368075 |
| 183 | Flat acetabular roof (HP:0003180) | 1.65682138 |
| 184 | Gonadotropin excess (HP:0000837) | 1.65646586 |
| 185 | Acute hepatic failure (HP:0006554) | 1.65280876 |
| 186 | Muscular hypotonia of the trunk (HP:0008936) | 1.64360751 |
| 187 | Elevated alkaline phosphatase (HP:0003155) | 1.63659841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K2 | 5.78252255 |
| 2 | EPHA4 | 4.14075095 |
| 3 | NTRK3 | 3.92910664 |
| 4 | AKT3 | 3.77361838 |
| 5 | MAP3K9 | 3.39223195 |
| 6 | DYRK1B | 3.31920773 |
| 7 | CASK | 3.02966585 |
| 8 | RIPK4 | 3.01594404 |
| 9 | MAP3K4 | 2.70113189 |
| 10 | MAP4K1 | 2.62049724 |
| 11 | CDK12 | 2.56823232 |
| 12 | KSR2 | 2.39497758 |
| 13 | DAPK2 | 2.24888832 |
| 14 | TXK | 2.24012723 |
| 15 | EPHA3 | 2.22917437 |
| 16 | MAP2K4 | 2.20621035 |
| 17 | MAP3K2 | 2.11593295 |
| 18 | MAP2K7 | 2.09196670 |
| 19 | CAMKK1 | 2.05403658 |
| 20 | MINK1 | 2.01646112 |
| 21 | PRKD3 | 1.90479083 |
| 22 | CAMKK2 | 1.86961953 |
| 23 | PAK6 | 1.78740504 |
| 24 | MAP3K12 | 1.76570246 |
| 25 | FRK | 1.68367713 |
| 26 | TRIB3 | 1.65909726 |
| 27 | RPS6KA4 | 1.64202567 |
| 28 | STK38L | 1.60381089 |
| 29 | NTRK1 | 1.57241764 |
| 30 | BCR | 1.49603170 |
| 31 | STK38 | 1.49193000 |
| 32 | MAPK13 | 1.48883980 |
| 33 | PASK | 1.44436538 |
| 34 | NEK9 | 1.43023192 |
| 35 | DAPK1 | 1.40486037 |
| 36 | RIPK1 | 1.40175341 |
| 37 | TAF1 | 1.39330025 |
| 38 | MAP3K13 | 1.38758414 |
| 39 | RET | 1.35978750 |
| 40 | ARAF | 1.35719073 |
| 41 | PIM2 | 1.34028514 |
| 42 | EEF2K | 1.32426403 |
| 43 | CDK5 | 1.30297024 |
| 44 | WNK4 | 1.30230178 |
| 45 | BMPR2 | 1.27215676 |
| 46 | CSNK1G2 | 1.25638191 |
| 47 | SRPK1 | 1.23988003 |
| 48 | MAP3K1 | 1.22283934 |
| 49 | PTK2B | 1.20973720 |
| 50 | KSR1 | 1.20562779 |
| 51 | CAMK1G | 1.17705283 |
| 52 | FES | 1.16994480 |
| 53 | BRAF | 1.15990313 |
| 54 | EIF2AK3 | 1.14609382 |
| 55 | FGFR4 | 1.12874602 |
| 56 | FER | 1.11608662 |
| 57 | CDK19 | 1.10394107 |
| 58 | PDK1 | 1.04476495 |
| 59 | RAF1 | 1.03792947 |
| 60 | BRD4 | 1.03332788 |
| 61 | SIK3 | 1.01738071 |
| 62 | MAP3K7 | 1.00835455 |
| 63 | PDPK1 | 0.98276277 |
| 64 | OXSR1 | 0.97905832 |
| 65 | EIF2AK1 | 0.95801641 |
| 66 | CDK6 | 0.95665239 |
| 67 | CAMK1 | 0.95636901 |
| 68 | GRK5 | 0.91784952 |
| 69 | NTRK2 | 0.91169431 |
| 70 | PAK3 | 0.90265101 |
| 71 | PRKCG | 0.89971176 |
| 72 | PRKCH | 0.89855784 |
| 73 | TAOK1 | 0.85236630 |
| 74 | PLK2 | 0.84356229 |
| 75 | CAMK2B | 0.83163821 |
| 76 | CDK3 | 0.82682339 |
| 77 | CAMK2A | 0.82604233 |
| 78 | EPHA2 | 0.81821658 |
| 79 | FGFR2 | 0.81651393 |
| 80 | SCYL2 | 0.81439567 |
| 81 | LMTK2 | 0.81230481 |
| 82 | PIM1 | 0.81136851 |
| 83 | MARK1 | 0.80168837 |
| 84 | TYRO3 | 0.77871432 |
| 85 | EPHB1 | 0.77766867 |
| 86 | PTK6 | 0.76308301 |
| 87 | CAMK1D | 0.75933514 |
| 88 | PINK1 | 0.75784250 |
| 89 | PKN2 | 0.74422402 |
| 90 | LRRK2 | 0.74411324 |
| 91 | SIK2 | 0.74110884 |
| 92 | STK11 | 0.73470091 |
| 93 | CDK7 | 0.73261881 |
| 94 | MAP2K2 | 0.72911423 |
| 95 | MARK2 | 0.71971223 |
| 96 | PIK3CA | 0.71402282 |
| 97 | INSRR | 0.71114910 |
| 98 | RPS6KB1 | 0.70605996 |
| 99 | GRK6 | 0.68943087 |
| 100 | TAOK3 | 0.67814160 |
| 101 | WNK1 | 0.67591638 |
| 102 | DYRK1A | 0.67250955 |
| 103 | SMG1 | 0.65585147 |
| 104 | MAP2K1 | 0.65231128 |
| 105 | STK39 | 0.64985561 |
| 106 | RPS6KB2 | 0.64083059 |
| 107 | CSNK1E | 0.63905079 |
| 108 | TNIK | 0.63289445 |
| 109 | DYRK3 | 0.62719928 |
| 110 | SGK1 | 0.62184751 |
| 111 | DMPK | 0.61105153 |
| 112 | YES1 | 0.60400788 |
| 113 | PDK4 | 0.59333146 |
| 114 | PDK3 | 0.59333146 |
| 115 | SGK3 | 0.59145384 |
| 116 | DYRK2 | 0.58964867 |
| 117 | JAK2 | 0.58724653 |
| 118 | SGK494 | 0.57914977 |
| 119 | SGK223 | 0.57914977 |
| 120 | BRSK2 | 0.57327182 |
| 121 | PRKCQ | 0.56724365 |
| 122 | ZAP70 | 0.55003042 |
| 123 | CSNK1A1L | 0.54724351 |
| 124 | HIPK2 | 0.52909878 |
| 125 | IRAK2 | 0.52884530 |
| 126 | CAMK2D | 0.50572235 |
| 127 | CLK1 | 0.50563265 |
| 128 | FYN | 0.50276344 |
| 129 | PTK2 | 0.49800923 |
| 130 | CSNK1G3 | 0.47713716 |
| 131 | CAMK2G | 0.47667647 |
| 132 | UHMK1 | 0.47240953 |
| 133 | PRKD1 | 0.46304873 |
| 134 | RPS6KL1 | 0.46213116 |
| 135 | RPS6KC1 | 0.46213116 |
| 136 | MATK | 0.44918490 |
| 137 | PRKCZ | 0.44774729 |
| 138 | CAMK4 | 0.44552738 |
| 139 | RPS6KA2 | 0.44503394 |
| 140 | PDGFRA | 0.44391905 |
| 141 | JAK1 | 0.43490574 |
| 142 | PRKD2 | 0.43018503 |
| 143 | TRIM28 | 0.41987043 |
| 144 | MAP3K6 | 0.41618237 |
| 145 | PRKCE | 0.40969894 |
| 146 | ERN1 | 0.40060911 |
| 147 | FLT3 | 0.39761243 |
| 148 | CDK14 | 0.39588110 |
| 149 | NME1 | 0.39084261 |
| 150 | CDK9 | 0.38940662 |
| 151 | SIK1 | 0.38139865 |
| 152 | SGK2 | 0.37950319 |
| 153 | TNK2 | 0.37638587 |
| 154 | MST1R | 0.36864686 |
| 155 | MAPK10 | 0.36376748 |
| 156 | FGR | 0.35077899 |
| 157 | ALK | 0.34395606 |
| 158 | MAP3K14 | 0.32543411 |
| 159 | EIF2AK2 | 0.32364491 |
| 160 | CSNK2A2 | 0.32171929 |
| 161 | NEK6 | 0.30807842 |
| 162 | PRKAA2 | 0.30714596 |
| 163 | FGFR3 | 0.30219668 |
| 164 | CDK2 | 0.29562141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.50833277 |
| 2 | Long-term potentiation_Homo sapiens_hsa04720 | 2.50710500 |
| 3 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46639368 |
| 4 | Retinol metabolism_Homo sapiens_hsa00830 | 2.40541499 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.31046510 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.13030641 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.11239245 |
| 8 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.09600950 |
| 9 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.09166783 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.06882474 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 2.06560031 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.96672499 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 1.96178767 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.95011414 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.94016425 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.91693570 |
| 17 | GABAergic synapse_Homo sapiens_hsa04727 | 1.86517237 |
| 18 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.84920734 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.84907897 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.83929920 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.83601837 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83176326 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.81590186 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.81160434 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77085871 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.77028461 |
| 27 | Olfactory transduction_Homo sapiens_hsa04740 | 1.76641273 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.73839214 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.73784490 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72092519 |
| 31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.69923601 |
| 32 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.69504684 |
| 33 | Morphine addiction_Homo sapiens_hsa05032 | 1.69124476 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66861388 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.66306543 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 1.64511485 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.62342718 |
| 38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.56122312 |
| 39 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.49717756 |
| 40 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.46902979 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.40503012 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.38935804 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.27923671 |
| 44 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.26521714 |
| 45 | Long-term depression_Homo sapiens_hsa04730 | 1.24314310 |
| 46 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.23873065 |
| 47 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.23105066 |
| 48 | Taste transduction_Homo sapiens_hsa04742 | 1.20689573 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.20465563 |
| 50 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.18887553 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.17707190 |
| 52 | Cocaine addiction_Homo sapiens_hsa05030 | 1.17158062 |
| 53 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.16287236 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.14716908 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.14701031 |
| 56 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.13636168 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13416096 |
| 58 | Basal transcription factors_Homo sapiens_hsa03022 | 1.09895337 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.09060486 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08689220 |
| 61 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.08528184 |
| 62 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.07941098 |
| 63 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.06567825 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06552313 |
| 65 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.06494245 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.06284966 |
| 67 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05263167 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 1.03162553 |
| 69 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.03133516 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.99364460 |
| 71 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97607196 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94155821 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94030627 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91045316 |
| 75 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89650472 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.88529741 |
| 77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.88106441 |
| 78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.87331623 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85596205 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.85155678 |
| 81 | Gap junction_Homo sapiens_hsa04540 | 0.85066294 |
| 82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.84413555 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83602191 |
| 84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.81239475 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80462070 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80114714 |
| 87 | Melanogenesis_Homo sapiens_hsa04916 | 0.78777433 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77975356 |
| 89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.76901033 |
| 90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76678466 |
| 91 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.75129918 |
| 92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.74457484 |
| 93 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.71894395 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71653326 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70714600 |
| 96 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70582129 |
| 97 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.70311590 |
| 98 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.69512171 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68880521 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68531402 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68020031 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68005274 |
| 103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66883770 |
| 104 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.66766323 |
| 105 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.66240681 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65391325 |
| 107 | Base excision repair_Homo sapiens_hsa03410 | 0.64255892 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.62681677 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.62410140 |
| 110 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.62118079 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61670323 |
| 112 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61434864 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60305463 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60110015 |
| 115 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.59766212 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58069560 |
| 117 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.57140955 |
| 118 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56913057 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56165453 |
| 120 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.56107641 |
| 121 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54021812 |
| 122 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53428213 |
| 123 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52841667 |
| 124 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52102621 |
| 125 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.49449525 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.49099851 |
| 127 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.48934450 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48207168 |
| 129 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47918580 |
| 130 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.47187789 |
| 131 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46899073 |
| 132 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46740201 |
| 133 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44623474 |
| 134 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44375883 |
| 135 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44321628 |
| 136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44284309 |
| 137 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44134312 |
| 138 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.43536284 |
| 139 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42549829 |
| 140 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41936886 |
| 141 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40856447 |
| 142 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40686153 |
| 143 | Axon guidance_Homo sapiens_hsa04360 | 0.40305462 |
| 144 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.39763132 |
| 145 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.39615174 |
| 146 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39232386 |
| 147 | ABC transporters_Homo sapiens_hsa02010 | 0.37500268 |
| 148 | Prion diseases_Homo sapiens_hsa05020 | 0.37091266 |
| 149 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35805569 |
| 150 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35180281 |
| 151 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35132669 |
| 152 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34854305 |
| 153 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34742203 |
| 154 | Endocytosis_Homo sapiens_hsa04144 | 0.34157419 |
| 155 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.33727684 |
| 156 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31163042 |
| 157 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.30479437 |
| 158 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30290146 |
| 159 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30248315 |
| 160 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.29856357 |
| 161 | Spliceosome_Homo sapiens_hsa03040 | 0.28913534 |
| 162 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27754981 |
| 163 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24883015 |
| 164 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.21308463 |

